272 related articles for article (PubMed ID: 20093527)
1. Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging.
Barajas RF; Hodgson JG; Chang JS; Vandenberg SR; Yeh RF; Parsa AT; McDermott MW; Berger MS; Dillon WP; Cha S
Radiology; 2010 Feb; 254(2):564-76. PubMed ID: 20093527
[TBL] [Abstract][Full Text] [Related]
2. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.
Barajas RF; Phillips JJ; Parvataneni R; Molinaro A; Essock-Burns E; Bourne G; Parsa AT; Aghi MK; McDermott MW; Berger MS; Cha S; Chang SM; Nelson SJ
Neuro Oncol; 2012 Jul; 14(7):942-54. PubMed ID: 22711606
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ
Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563
[TBL] [Abstract][Full Text] [Related]
4. Pro-angiogenic cellular and genomic expression patterns within glioblastoma influences dynamic susceptibility weighted perfusion MRI.
Barajas RF; Phillips JJ; Vandenberg SR; McDermott MW; Berger MS; Dillon WP; Cha S
Clin Radiol; 2015 Oct; 70(10):1087-95. PubMed ID: 26231469
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
Gevaert O; Mitchell LA; Achrol AS; Xu J; Echegaray S; Steinberg GK; Cheshier SH; Napel S; Zaharchuk G; Plevritis SK
Radiology; 2014 Oct; 273(1):168-74. PubMed ID: 24827998
[TBL] [Abstract][Full Text] [Related]
6. Super-resolution track density imaging of glioblastoma: histopathologic correlation.
Barajas RF; Hess CP; Phillips JJ; Von Morze CJ; Yu JP; Chang SM; Nelson SJ; McDermott MW; Berger MS; Cha S
AJNR Am J Neuroradiol; 2013 Jul; 34(7):1319-25. PubMed ID: 23413250
[TBL] [Abstract][Full Text] [Related]
7. Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.
van Dijken BRJ; Jan van Laar P; Li C; Yan JL; Boonzaier NR; Price SJ; ; van der Hoorn A
J Neurosurg; 2018 Oct; 131(3):717-723. PubMed ID: 30485234
[TBL] [Abstract][Full Text] [Related]
8. Molecular differences between cerebral blood volume and vessel size in glioblastoma multiforme.
Heiland DH; Demerath T; Kellner E; Kiselev VG; Pfeifer D; Schnell O; Staszewski O; Urbach H; Weyerbrock A; Mader I
Oncotarget; 2017 Feb; 8(7):11083-11093. PubMed ID: 27613830
[TBL] [Abstract][Full Text] [Related]
9. Brain Tumors: The Influence of Tumor Type and Routine MR Imaging Characteristics at BOLD Functional MR Imaging in the Primary Motor Gyrus.
Fraga de Abreu VH; Peck KK; Petrovich-Brennan NM; Woo KM; Holodny AI
Radiology; 2016 Dec; 281(3):876-883. PubMed ID: 27383533
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death.
Colen RR; Wang J; Singh SK; Gutman DA; Zinn PO
Radiology; 2015 Apr; 275(1):215-27. PubMed ID: 25490189
[TBL] [Abstract][Full Text] [Related]
11. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
Knopp EA; Cha S; Johnson G; Mazumdar A; Golfinos JG; Zagzag D; Miller DC; Kelly PJ; Kricheff II
Radiology; 1999 Jun; 211(3):791-8. PubMed ID: 10352608
[TBL] [Abstract][Full Text] [Related]
12. Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.
Jain R; Poisson LM; Gutman D; Scarpace L; Hwang SN; Holder CA; Wintermark M; Rao A; Colen RR; Kirby J; Freymann J; Jaffe CC; Mikkelsen T; Flanders A
Radiology; 2014 Aug; 272(2):484-93. PubMed ID: 24646147
[TBL] [Abstract][Full Text] [Related]
13. MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set.
Gutman DA; Cooper LA; Hwang SN; Holder CA; Gao J; Aurora TD; Dunn WD; Scarpace L; Mikkelsen T; Jain R; Wintermark M; Jilwan M; Raghavan P; Huang E; Clifford RJ; Mongkolwat P; Kleper V; Freymann J; Kirby J; Zinn PO; Moreno CS; Jaffe C; Colen R; Rubin DL; Saltz J; Flanders A; Brat DJ
Radiology; 2013 May; 267(2):560-9. PubMed ID: 23392431
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Barajas RF; Chang JS; Segal MR; Parsa AT; McDermott MW; Berger MS; Cha S
Radiology; 2009 Nov; 253(2):486-96. PubMed ID: 19789240
[TBL] [Abstract][Full Text] [Related]
16. Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.
Jamshidi N; Diehn M; Bredel M; Kuo MD
Radiology; 2014 Jan; 270(1):1-2. PubMed ID: 24056404
[TBL] [Abstract][Full Text] [Related]
17. MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma.
Gill BJ; Pisapia DJ; Malone HR; Goldstein H; Lei L; Sonabend A; Yun J; Samanamud J; Sims JS; Banu M; Dovas A; Teich AF; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Sims PA; Canoll P
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12550-5. PubMed ID: 25114226
[TBL] [Abstract][Full Text] [Related]
18. Discrimination between Glioblastoma and Solitary Brain Metastasis: Comparison of Inflow-Based Vascular-Space-Occupancy and Dynamic Susceptibility Contrast MR Imaging.
Li X; Wang D; Liao S; Guo L; Xiao X; Liu X; Xu Y; Hua J; Pillai JJ; Wu Y
AJNR Am J Neuroradiol; 2020 Apr; 41(4):583-590. PubMed ID: 32139428
[TBL] [Abstract][Full Text] [Related]
19. Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis.
Pope WB; Chen JH; Dong J; Carlson MR; Perlina A; Cloughesy TF; Liau LM; Mischel PS; Nghiemphu P; Lai A; Nelson SF
Radiology; 2008 Oct; 249(1):268-77. PubMed ID: 18796682
[TBL] [Abstract][Full Text] [Related]
20. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
